<DOC>
	<DOCNO>NCT02308332</DOCNO>
	<brief_summary>This study evaluate effect switch Atripla Eviplera neurocognition measure neuropsychological test functional MRI</brief_summary>
	<brief_title>Effect SwitChing AtriPla Eviplera Neurocognitive Emotional Functioning</brief_title>
	<detailed_description>Efavirenz , antiretroviral drug use treatment human immunodeficiency virus 1 ( HIV-1 ) infection , know neurological psychiatric adverse event . Efavirenz part Atripla® , single tablet regimen ( STR ) , currently prescribe antiretroviral drug Netherlands . Recently , new STR become available , Eviplera® contain successor Efavirenz , name Rilpivirin . It show phase-3 ECHO THRIVE study Atripla well Eviplera excellent comparable antiretroviral efficacy naive HIV-infected patient . Furthermore , data study show Eviplera associate few neurological psychiatric adverse event Atripla 48 week . However , patient report adverse event , neuropsychological evaluation . Furthermore , treatment naïve HIV . Moreover , might bias kind switch study due fact patient switch mostly regard new combination well old one . Contrary , data long term impact Efavirenz neuropsychological performance symptom conflict . Objective : This study aim investigate effect switch Atripla Eviplera neurocognitive performance ( neurocognitive testing ) imaging ( functional MRI scanning ) virologically suppress HIV-infected patient .</detailed_description>
	<mesh_term>Neurocognitive Disorders</mesh_term>
	<mesh_term>Emtricitabine</mesh_term>
	<mesh_term>Rilpivirine</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<mesh_term>Efavirenz , Emtricitabine , Tenofovir Disoproxil Fumarate Drug Combination</mesh_term>
	<criteria>Male , 30 50 year HIV1 RNA &lt; 50 copies/mL screen visit Atripla continuously ≥6 month precede screen visit Have HIV genotype prior start cART Atripla know resistance study agent time past include , limited RT mutation K65R , K101E/P , E138G/K/Q/R , Y181C/I/V , M184V/I H221Y Negative TPHA VDRL &lt; 12 month prior screen visit sign acute chronic hepatitis C infection within past 12 month screen define Dutch guideline ( Arends et al . Neth J Med 2011 ) No subjective neurocognitive complaint precede 12 month willingness take Eviplera together food accord manufacturer 's prescription . Estimated glomerular filtration rate ≥50 mL/min ( CockcroftGault formula ) last routine measurement outpatient clinic able understand comply study procedure provide write informed consent Nonnative Dutch speaker Proven major depression psychiatric consultation within past year antidepressant drug ( SSRI TCA ) Active know medical history past CNS opportunistic infection History proven neurologic disease ( e.g . multiple sclerosis , brain tumor , cerebrovascular event , etc ) Active psychiatric disorder classify accord DMS V criterion History evidence alcohol drug abuse define accord DSM V criterion TSH within normal reference value last routine measurement outpatient clinic Contraindications undergoing MRI ; pacemaker metallic devices/foreign body situ , proven claustrophobia .</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>